Global Immunoassay Market Research Report

Immunoassay accounted for 26% share of the IVD market in 2013. The recent technological development focuses more on detecting one or several proteins in a patient’s blood or serum. The growth of the immunoassays market will primarily be dependent on the development of novel assays in prime areas, such as cardiology, oncology, and various autoimmune diseases, as these novel assays will help companies gain a competitive edge. The rising automation trend is a major driver for the growth of the immunoassay market as it helps reduce the cost of labor, which accounts for around 50% of the total cost of a test.

The Centers for Medicare & Medicaid Services (CMS) has estimated that healthcare spending in the U.S. is expected to grow from $2.7 trillion in 2011 to about $4.6 trillion in 2018, at a CAGR of 6.8% for the same period. Similarly, in emerging countries, the growing awareness and the increasing middle-class population, with more disposable incomes to spend on healthcare, will be the major driving factors for the growth of this market.

The report analyzes the market by two segments, namely, immunoassay reagents and immunoassay instruments. These two segments experienced a positive growth till 2013, with a market value of $12.5 billion, comprising $10.59 billion for immunoassay reagents and $1.97 billion for immunoassay instruments, with the overall market projected to grow at a CAGR of 8.5% during the forecast period.

The Americas commanded the largest share of 42% of the immunoassay market at an estimated $5,248.2 million in 2013 and the region is expected to reach $7,563.2 million by 2018, at a CAGR of 8% from 2013 to 2018. Europe holds the second largest market position. From the European region, Germany commanded the largest share of 20% of the immunoassay market at an estimated $790.6 million in 2013 and is expected to reach $1,066.7 million by 2018, at a CAGR of 6.5% from 2013 to 2018. The Asian immunoassay market is growing in double digits and will continue to grow in future. China commanded the largest share 53% of the immunoassay market at an estimated $626.0 million in 2013 and is expected to reach $,1309.0 million by 2018, at a CAGR of 16.7% from 2013 to 2018.

The report also provides an extensive competitive landscaping of the leading companies operating in immunoassay market. The major players of the immunoassay market are Siemens (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Ortho Clinical Diagnostics (U.S.), and bioMerieux SA (France). The segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies in immunoassay market have been detailed in this report.

Customization Options:

Along with market data, customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and a deep dive analysis of the following parameters:

Opportunity Analysis:

• The unmet needs, revenue pockets, and potential areas for the expansion of immunoassay market
• A comprehensive review of the key component providers, analyzers, and test kit providers in the immunoassay market

Current and Emerging Products:

• An analysis of the current and emerging immunoassay and immunodiagnostic tests
• A review of current instrumentation technologies in immunoassay

Pricing Trends:

• Pricing trend of immunoassay tests

Product Analysis

• Usage pattern (in-depth trend analysis) of products (segment-wise)
• Product matrix, which gives a detailed comparison of product portfolio of each company, mapped at country and sub-segment levels
• End-user adoption rate analysis of the products (segment-wise and country-wise)
• A comprehensive coverage of product approvals, pipeline products, and product recalls

Brand/Product Perception Matrix:

• A comprehensive study of customers’ perception and behavior through our inbuilt social connect tool checking the virility and tonality of blogs
• An analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)

Alternative Products: Impact analysis

MMM’s Healthcare Decision Making Quadrant: It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters such as patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate, and healthcare expenditure)

1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
 

2 Executive Summary
 

3 Market Overview
 

4 By Applications
4.1 Cancer
4.2 Endocrine disorders
4.3 Cardiovascular Disorders
4.4 Infectious disease
4.5 Auto-immune Diseases
4.6 Blood Disorders
4.7 Bone and Mineral Disorders
4.8 Toxicology Screening
 

5 By Endusers
5.1 Hospitals
5.2 Medical & Diagnostic Laboratories
5.3 Pharmaceuticals
5.4 Contract Research Organization (CRO)
 

6 By Types
6.1 Medium Throughput
6.2 Low Throughput
6.3 High Throughput
 

7 By Technologies
7.1 Enzyme Immunoassays (EIA)
7.2 Fluorescence Immunoassays (FIA)
7.3 Chemiluminescence Immunoassays (CLIA)
7.4 Radioimmunoassays (RIA)
 

8 By Products
8.1 Immunoassay Instruments
8.2 Immunoassay Reagents
8.3 Immunoassay Services
 

9 By Geographies
9.1 Americas
9.2 Europe
9.3 Asia-Pacific
9.4 Rest of World
 

10 By Companies
10.1 Siemens AG Healthcare
10.2 Johnson & Johnson
10.3 BioMérieux
10.4 Abbott Laboratories

Please fill in the form below to receive a free copy of the Summary of this Report

* First Name :

* Last Name :

* Designation :

* Company :

* Email(Username) :

* Phone :

* Country :

-- Select Country -- India Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antigua Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia Herzegovina Botswana Brazil British Virgin Island Brunei Darussalam Bulgaria Burkina Faso Burundi Cote d'Ivoire Cambodia Cameroon Canada Cape Verde Cayman Isls Central African Republic Chad Chile China Colombia Comoros Congo Cook Island Costa Rica Croatia Cuba Cyprus Czech Republic Democratic People's Republic of Korea Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Faroe Islands Falkland Islands (Malvinas) Fiji Finl France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenl Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Holy See Honduras Hong Kong Special Administrative Hungary Iceland Indonesia Iran (Islamic Republic of Iran) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Special Administrative Region of China Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Micronesia Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherland Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Islands Northern Mariana Islands Norway Occupied Palestinian Territory Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Republic of Korea Republic of Moldova Romania Russian Federation Rwa Saint Helena Saint Kitts Nevis Saint Lucia Saint Pierre Miquelon Saint Vincent the Grenadines Samoa San Marino Sao Tome Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka Sudan Suriname Svalbard Jan Mayen Islands Swazil Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Togo Tokelau Tonga Trinidad Tobago Tunisia Turkey Turkmenistan Turks Caicos Isls Tuvalu Uga Ukraine United Arab Emirates United Kingdom United Republic of Tanzania United States United States Virgin Isls Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Wallis Futuna Isls Western Sahara Yemen Yugoslavia Zambia Zimbabwe

Comments :

Reports Interested in :Global Immunoassay Market Research Report

* Enter the text from the image to the text box :